Adding Lidocaine to Intranasal Midazolam Did Not Improve This Small Pediatric Trial

A proposed comfort modification requires outcome data; its rationale alone does not establish reduced distress.

What the supplied source reports

Forty-two children undergoing myringotomy and tube placement were randomized among intranasal saline, midazolam and midazolam plus lidocaine. Recovery-unit discharge times did not differ significantly. Lidocaine addition did not improve efficacy or tolerability; verbal complaints during administration were highest in that group. Parent and nurse distress assessments did not produce identical findings.

Limits of the evidence

Only fourteen children were included per group, and recruitment ended with practical enrollment constraints. The results concern a particular formulation mixture, selected low-risk children and a specific operation. Nonsignificant discharge differences cannot establish universal equivalence.

Implications for forensic interpretation

For reviewing premedication, distinguish discomfort during administration from anxiety at induction and later recovery. Identify whose rating was recorded and when. A medicine intended to reduce nasal discomfort can still fail to improve the measured experience; the entire administration sequence matters when interpreting a child’s distress.

Source and related reading

Source reviewed: Intranasal Midazolam With Lidocaine for Sedation in Pediatric Myringotomy and Tube Surgery A Randomi (PMC9312809). Forensic applications above are interpretive analysis of the supplied publication.